Northpointe Bancshares, Inc. (NPB)
NYSE: NPB · Real-Time Price · USD
14.18
+0.06 (0.42%)
At close: Jun 27, 2025, 4:00 PM
14.18
0.00 (0.00%)
After-hours: Jun 27, 2025, 7:00 PM EDT
Northpointe Bancshares Revenue
Northpointe Bancshares had revenue of $54.02M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $195.58M. In the year 2024, Northpointe Bancshares had annual revenue of $185.77M, down -6.07%.
Revenue (ttm)
$195.58M
Revenue Growth
-6.07%
P/S Ratio
1.94
Revenue / Employee
$391,164
Employees
500
Market Cap
487.29M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 185.77M | -12.01M | -6.07% |
Dec 31, 2023 | 197.77M | -57.57M | -22.55% |
Dec 31, 2022 | 255.34M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNPB News
- 7 days ago - Northpointe Bancshares, Inc. Announces Date of Second Quarter 2025 Earnings Release and Conference Call - Business Wire
- 2 months ago - Northpointe Bancshares, Inc. Reports First Quarter 2025 Results - Business Wire
- 2 months ago - Northpointe Welcomes Patrick Collins as Senior Vice President of Mortgage Warehouse Lending - Business Wire
- 2 months ago - Northpointe Bancshares, Inc. Declares Quarterly Cash Dividend on Common Stock - Business Wire
- 3 months ago - Northpointe Bancshares, Inc. Announces Date of First Quarter 2025 Earnings Release and Conference Call - Business Wire
- 4 months ago - U.S. IPO Weekly Recap: Big Listings Post Mixed Results In Busy 7 IPO Week - Seeking Alpha
- 4 months ago - Northpointe Bancshares, Inc. (“Northpointe”), Announced Today the Pricing of Its Initial Public Offering - Business Wire
- 4 months ago - U.S. IPO Weekly Recap: Cement And Cystic Fibrosis Drugs Lead A 6 IPO Week - Seeking Alpha